Tacoma, WA · Founded 2000 · Privately Held (backing)
Developer of an anti-inflammatory therapeutic drug designed to treat a variety of neurological diseases. Revalesio is based in Tacoma, WA and was founded in 2000. Its last reported valuation was $86.4 million in Jul 2020. It has raised $113 million across 6 recorded rounds; the latest was a $38.9 million early-stage round in May 2022.
Last reported valuation
$86.4M
Oct 2026
Priced at
—
Total raised
$112.8M
Last round
Early Stage VC
May 2022
Team — not yet on record
No current team members for Revalesio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Revalesio with a free account
·Watch Revalesio: the Monday email on marks, rounds and moves
